Suppr超能文献

一种高度适形的海马体保留全脑放射治疗新方法:一项可行性研究。

A New Approach to Highly Conformal Hippocampal-sparing Whole-brain Radiotherapy: A Feasibility Study.

作者信息

Ziemann Christian, Cremers Florian, MacPherson Miller, Rades Dirk, Löser Anastassia

机构信息

Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;

Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.

出版信息

In Vivo. 2025 Mar-Apr;39(2):834-843. doi: 10.21873/invivo.13886.

Abstract

BACKGROUND/AIM: Hippocampal-sparing whole-brain radiotherapy (HS-WBRT) is increasingly used for multiple brain metastases. However, most studies have not reported dose conformity indices (). In the only study indicating the , conformity was low (=0.7). We developed a new technique to achieve a significantly higher and better dose coverage.

PATIENTS AND METHODS

Ten patients received 30 Gy of HS-WBRT for brain metastases. Three variants of treatment plans (VAR1, VAR2, VAR3) were investigated. Volumetric modulated arc therapy plans with two (2ROT) or three rotations (3ROT) were created for each variant. Plans were compared for compliance with hippocampal sparing criteria, (where a higher value indicates better conformity), and homogeneity index (, where a lower value indicates better homogeneity).

RESULTS

Best results (highest , lowest ) were achieved with the VAR3-3ROT technique (a new method), which yielded a =0.92-0.95 and a =0.05-0.09. VAR3-2ROT led to a =0.90-0.95 and a =0.06-0.11. With the other techniques, and ranged between 0.77-0.87 and 0.15-0.32, respectively.

CONCLUSION

Our new technique achieved both appropriate hippocampal sparing and very high dose conformity of ≥0.9. Significant underdosage outside the hippocampal-sparing area was avoided.

摘要

背景/目的:海马体保留全脑放疗(HS-WBRT)越来越多地用于多发性脑转移瘤。然而,大多数研究并未报告剂量适形指数()。在唯一一项表明该指数的研究中,适形性较低(=0.7)。我们开发了一种新技术,以实现显著更高的指数和更好的剂量覆盖。

患者与方法

10例脑转移瘤患者接受了30 Gy的HS-WBRT。研究了三种治疗计划变体(VAR1、VAR2、VAR3)。为每个变体创建了具有两次(2ROT)或三次旋转(3ROT)的容积调强弧形治疗计划。比较各计划是否符合海马体保留标准、指数(值越高表明适形性越好)和均匀性指数(值越低表明均匀性越好)。

结果

VAR3-3ROT技术(一种新方法)取得了最佳结果(最高指数,最低指数),其指数=0.92 - 0.95,指数=0.05 - 0.09。VAR3-2ROT的指数=0.90 - 0.95,指数=0.06 - 0.11。采用其他技术时,指数和指数分别在0.77 - 0.87和0.15 - 0.32之间。

结论

我们的新技术既实现了适当的海马体保留,又达到了≥0.9的非常高的剂量适形性。避免了海马体保留区域外的显著剂量不足。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d403/11884443/bc8a77566a06/in_vivo-39-837-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验